High incidence and intraclonal heterogeneity of chromosome 11 aberrations in patients with newly diagnosed multiple myeloma detected by multiprobe interphase FISH

Cancer Genetics and Cytogenetics

Volumn 161, Issue 2, 2005, Pages 116-124

  Cremer, Friedrich W ^a   Kartal, Mutlu ^a   Hose, Dirk ^a   Bila, Jelena ^a   Buck, Isabelle ^a   Bellos, Frauke ^a   Raab, Marc Steffen ^a   Brough, Michaela ^a   Moebus, Anke ^a   Hager, Hans Dieter ^a   Goldschmidt, Hartmut ^a   Moos, Marion ^a   Bartram, Claus R ^a   Jauch, Anna ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

SYNDECAN 1;

ADULT; AGED; ARTICLE; BONE MARROW; CHROMOSOME 11; CHROMOSOME 11Q; CHROMOSOME 13Q; CHROMOSOME 14; CHROMOSOME ABERRATION; CHROMOSOME DELETION 13; CHROMOSOME DUPLICATION; CHROMOSOME NUMBER; CHROMOSOME STRUCTURE; CHROMOSOME TRANSLOCATION; CONTROLLED STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE LOCUS; GENE PROBE; GENETIC HETEROGENEITY; HUMAN; HUMAN CELL; INTERPHASE; MAJOR CLINICAL STUDY; MALE; MOLECULAR CLONING; MULTIPLE MYELOMA; PLASMA CELL; PRIORITY JOURNAL; PROGNOSIS; TETRASOMY; TRISOMY; TRISOMY 11;

ADULT; AGED; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 13; CLONE CELLS; DNA PROBES; FEMALE; GENETIC HETEROGENEITY; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INCIDENCE; INTERPHASE; MALE; MIDDLE AGED; MULTIPLE MYELOMA; TRANSLOCATION, GENETIC;

EID: 23644441521     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2005.02.015     Document Type: Article

References (36)

1. M. Flactif, M. Zandecki, J.L. Lai, F. Bernardi, V. Obein, F. Bauters, and T. Facon Interphase fluorescence in situ hybridization (FISH) as a powerful tool for the detection of aneuploidy in multiple myeloma Leukemia 9 1995 2109 2114
2. M. Hallek, P.L. Bergsagel, and K.C. Anderson Multiple myeloma: increasing evidence for a multistep transformation process Blood 91 1998 3 21
3. J.R. Sawyer, J.L. Lukacs, E.L. Thomas, C.M. Swanson, L.S. Goosen, G. Sammartino, J.C. Gilliland, N.C. Munshi, G. Tricot, J.D. Shaughnessy Jr., and B. Barlogie Multicolour spectral karyotyping identifies new translocations and a recurring pathway for chromosome loss in multiple myeloma Br J Haematol 112 2001 167 174
4. G. Pratt Molecular aspects of multiple myeloma Mol Pathol 55 2002 273 283
5. H.J. Weh, K. Gutensohn, J. Selbach, R. Kruse, G. Wacker-Backhaus, D. Seeger, W. Fiedler, W. Fett, and D.K. Hossfeld Karyotype in multiple myeloma and plasma cell leukaemia Eur J Cancer 29A 1993 1269 1273
6. T. Nilsson, M. Höglund, S. Lenhoff, L. Rylander, I. Turesson, J. Westin, F. Mitelman, and B. Johansson A pooled analysis of karyotypic patterns, breakpoints and imbalances in 783 cytogenetically abnormal multiple myelomas reveals frequently involved chromosome segments as well as significant age- and sex-related differences Br J Haematol 120 2003 960 969
7. S. Stilgenbauer, P. Liebisch, M.R. James, M. Schroder, B. Schlegelberger, K. Fischer, M. Bentz, P. Lichter, and H. Dohner Molecular cytogenetic delineation of a novel critical genomic region in chromosome bands 11q22.3-q23.1 in lymphoproliferative disorders Proc Natl Acad Sci U S A 93 1996 11837 11841
8. P.L. Bergsagel, and W.M. Kuehl Critical roles for immunoglobulin translocations and cyclin D dysregulation in multiple myeloma Immunol Rev 194 2003 96 104
9. H. Avet-Loiseau, L.E. Andree-Ashley, D. Moore 2nd, M.P. Mellerin, J. Feusner, R. Bataille, and M.G. Pallavicini Molecular cytogenetic abnormalities in multiple myeloma and plasma cell leukemia measured using comparative genomic hybridization Genes Chromosomes Cancer 19 1997 124 133
10. J.C. Cigudosa, P.H. Rao, M.J. Calasanz, M.D. Odero, J. Michaeli, S.C. Jhanwar, and R.S. Chaganti Characterization of nonrandom chromosomal gains and losses in multiple myeloma by comparative genomic hybridization Blood 91 1998 3007 3010
11. N.C. Gutierrez, J.M. Hernandez, J.L. Garcia, M.C. Canizo, M. Gonzalez, J. Hernandez, M.B. Gonzalez, M.A. Garcia-Marcos, and J.F. San Miguel Differences in genetic changes between multiple myeloma and plasma cell leukemia demonstrated by comparative genomic hybridization Leukemia 15 2001 840 845
12. P. Liebisch, A. Viardot, N. Bassermann, C. Wendl, K. Roth, H. Goldschmidt, H. Einsele, C. Straka, S. Stilgenbauer, H. Dohner, and M. Bentz Value of comparative genomic hybridization and fluorescence in situ hybridization for molecular diagnostics in multiple myeloma Br J Haematol 122 2003 193 201
13. D. Tabernero, J.F. San Miguel, M. Garcia-Sanz, L. Najera, M. Garcia-Isidoro, J.A. Perez-Simon, M. Gonzalez, J. Wiegant, A.K. Raap, and A. Orfao Incidence of chromosome numerical changes in multiple myeloma: fluorescence in situ hybridization analysis using 15 chromosome-specific probes Am J Pathol 149 1996 153 161
14. R. Königsberg, N. Zojer, J. Ackermann, E. Kromer, H. Kittler, E. Fritz, H. Kaufmann, T. Nosslinger, L. Riedl, H. Gisslinger, U. Jager, I. Simonitsch, R. Heinz, H. Ludwig, H. Huber, and J. Drach Predictive role of interphase cytogenetics for survival of patients with multiple myeloma J Clin Oncol 18 2000 804 812
15. P. Liebisch, C. Wendl, A. Wellmann, A. Krober, G. Schilling, H. Goldschmidt, H. Einsele, C. Straka, M. Bentz, S. Stilgenbauer, and H. Dohner High incidence of trisomies 1q, 9q, and 11q in multiple myeloma: results from a comprehensive molecular cytogenetic analysis [Letter] Leukemia 17 2003 2535 2537
16. M.B. Gonzalez, J.M. Hernandez, J.L. Garcia, E. Lumbreras, M. Castellanos, J.M. Hernandez, J. Fernandez-Calvo, N.C. Gutierrez, and J.F. San Miguel The value of fluorescence in situ hybridization for the detection of 11q in multiple myeloma Haematologica 89 2004 1213 1218
17. H. Avet-Loiseau, J.Y. Li, T. Facon, C. Brigaudeau, N. Morineau, F. Maloisel, M.J. Rapp, P. Talmant, F. Trimoreau, A. Jaccard, J.L. Harousseau, and R. Bataille High incidence of translocations t(11;14)(q13;q32) and t(4;14) (p16;q32) in patients with plasma cell malignancies Cancer Res 58 1998 5640 5645
18. R. Fonseca, E.A. Blood, M.M. Oken, R.A. Kyle, G.W. Dewald, R.J. Bailey, S.A. Van Wier, K.J. Henderson, J.D. Hoyer, D. Harrington, N.E. Kay, B. Van Ness, and P.R. Greipp Myeloma and the t(11;14)(q13;q32); evidence for a biologically defined unique subset of patients Blood 99 2002 3735 3741
19. P. Moreau, T. Facon, X. Leleu, N. Morineau, P. Huyghe, J.L. Harousseau, R. Bataille, H. Avet-Loiseau, and Intergroupe Francophone du Myelome Recurrent 14q32 translocations determine the prognosis of multiple myeloma, especially in patients receiving intensive chemotherapy Blood 100 2002 1579 1583
20. G. Tricot, B. Barlogie, S. Jagannath, D. Bracy, S. Mattox, D.H. Vesole, S. Naucke, and J.R. Sawyer Poor prognosis in multiple myeloma is associated only with partial or complete deletions of chromosome 13 or abnormalities involving 11q and not with other karyotype abnormalities Blood 86 1995 4250 4256
21. N.C. Gutierrez, J.M. Hernandez, J.L. Garcia, J. Almeida, G. Mateo, M.I. Gonzalez, J. Hernandez, J. Fernandez-Calvo, and J.F. San Miguel Correlation between cytogenetic abnormalities and disease characteristics in multiple myeloma: monosomy of chromosome 13 and structural abnormalities of 11q are associated with a high percentage of S-phase plasma cells Haematologica 85 2000 1146 1152
22. S. Soverini, M. Cavo, C. Cellini, C. Terragna, E. Zamagni, D. Ruggeri, N. Testoni, P. Tosi, A. De Vivo, M. Amabile, T. Grafone, E. Ottaviani, B. Giannini, D. Cangini, F. Bonifazi, A. Neri, S. Fabris, S. Tura, M. Baccarani, and G. Martinelli Cyclin D1 overexpression is a favorable prognostic variable for newly diagnosed multiple myeloma patients treated with high-dose chemotherapy and single or double autologous transplantation Blood 102 2003 1588 1594
23. N.C. Gutierrez, J.L. Garcia, J.M. Hernandez, E. Lumbreras, M. Castellanos, A. Rasillo, G. Mateo, J.M. Hernandez, S. Perez, A. Orfao, and J.F. San Miguel Izquierdo Prognostic and biological significance of chromosomal imbalances assessed by comparative genomic hybridization in multiple myeloma Blood 104 2004 2661 2666
24. W. Hoechtlen-Vollmar, G. Menzel, R. Bartl, R. Lamerz, M. Wick, and D. Seidel Amplification of cyclin D1 gene in multiple myeloma: clinical and prognostic relevance Br J Haematol 109 2000 30 38
25. K. Specht, E. Haralambieva, K. Bink, M. Kremer, S. Mandl-Weber, I. Koch, R. Tomer, H. Hofler, E. Schuuring, P.M. Kluin, F. Fend, and L. Quintanilla-Martinez Different mechanisms of cyclin D1 overexpression in multiple myeloma revealed by fluorescence in situ hybridization and quantitative analysis of mRNA levels Blood 104 2004 1120 1126
26. P. Lichter, and T. Cremer Chromosome analysis by non-isotopic in situ hybridization D.E. Rooney B.H. Czepulkowski Human cytogenetics 1992 Oxford University Press New York 157 192
27. J. Blade, D. Samson, D. Reece, J. Apperley, B. Bjorkstrand, G. Gahrton, M. Gertz, S. Giralt, S. Jagannath, and D. Vesole Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation Br J Haematol 102 1998 1115 1123
28. R. Ihaka, and R. Gentlemen A language for data analysis and graphics J Comput Graph Stat 5 1996 299 314
29. L. Michaux, I. Wlodarska, M. Stul, J. Dierlamm, F. Mugneret, C. Herens, B. Beverloo, A. Verhest, C. Verellen-Dumoulin, G. Verhoef, D. Selleslag, V. Madoe, M. Lecomte, B. Deprijck, A. Ferrant, A. Delannoy, S. Marichal, C. Duhem, M. Dicato, and A. Hagemeijer MLL amplification in myeloid leukemias: a study of 14 cases with multiple copies of 11q23 Genes Chromosomes Cancer 29 2000 40 47
30. M.A. Caligiuri, M.P. Strout, D. Lawrence, D.C. Arthur, M.R. Baer, F. Yu, S. Knuutila, K. Mrozek, A.R. Oberkircher, G. Marcucci, A. de la Chapelle, E. Elonen, A.W. Block, P.N. Rao, G.P. Herzig, B.L. Powell, T. Ruutu, C.A. Schiffer, and C.D. Bloomfield Rearrangement of ALL1 (MLL) in acute myeloid leukemia with normal cytogenetics Cancer Res 58 1998 55 59
31. N. Akiyama, H. Tsuruta, H. Sasaki, H. Sakamoto, M. Hamaguchi, Y. Ohmura, M. Seto, R. Ueda, H. Hirai, and Y. Yazaki Messenger RNA levels of five genes located at chromosome 11q13 in B-cell tumors with chromosome translocation t(11;14)(q13;q32) Cancer Res 54 1994 377 379
32. A. Gabrea, P.L. Bergsagel, M. Chesi, Y. Shou, and W.M. Kuehl Insertion of excised IgH switch sequences causes overexpression of cyclin D1 in a myeloma tumor cell Mol Cell 3 1999 119 123
33. F. Toledo, D. Le Roscouet, G. Buttin, and M. Debatisse Co-amplified markers alternate in megabase long chromosomal inverted repeats and cluster independently in interphase nuclei at early steps of mammalian gene amplification EMBO J 11 1992 2665 2673
34. N.V. Smadja, D. Leroux, J. Soulier, S. Dumont, C. Arnould, S. Taviaux, J.L. Taillemite, and C. Bastard Further cytogenetic characterization of multiple myeloma confirms that 14q32 translocations are a very rare event in hyperdiploid cases Genes Chromosomes Cancer 38 2003 234 239
35. J. Shaughnessy, E. Tian, J. Sawyer, K. Bumm, R. Landes, A. Badros, C. Morris, G. Tricot, J. Epstein, and B. Barlogie High incidence of chromosome 13 deletion in multiple myeloma detected by multiprobe interphase FISH Blood 96 2000 1505 1511
36. G. Tricot, T. Spencer, J. Sawyer, D. Spoon, R. Desikan, A. Fassas, A. Badros, M. Zangari, N. Munshi, E. Anaissie, A. Toor, and B. Barlogie Predicting long-term (≥5 years) event-free survival in multiple myeloma patients following planned tandem autotransplants Br J Haematol 116 2002 211 217